Examinando por Autor "Araya-Maturana, Ramiro"

Mostrando 1 - 2 de 2
  • No hay miniatura disponible
    Ítem
    9,10-dihydroxy-4,4-dimethyl-5,8-dihydroanthracen-1(4H)-one
    (International Union of Crystallography, 2008-07-01) Ramirez-Rodriguez, Oney; Martinez-Cifuentes, Maximiliano; Ibanez, Andres; Vega, Andres; Araya-Maturana, Ramiro
    In the title molecule, C16H16O3, the ring system is planar and an intramolecular hydrogen bond is present. The molecular packing is dominated by an intermolecular hydrogen bond and by pi-stacking interactions [interplanar separation 3.8012 angstrom].
  • No hay miniatura disponible
    Ítem
    Fri-1 is an anti-cancer isoquinolinequinone that inhibits the mitochondrial bioenergetics and blocks metabolic shifts by redox disruption in breast cancer cells
    (MDPI, 2021-10) Córdova-Delgado, Miguel; Fuentes-Retamal, Sebastián; Palominos, Charlotte; López-Torres, Camila; Guzmán-Rivera, Daniela; Ramírez-Rodríguez, Oney; Araya-Maturana, Ramiro; Urra, Félix A.
    Since breast cancer (BC) cells are dependent on mitochondrial bioenergetics for promoting proliferation, survival, and metastasis, mitochondria highlight as an important target for anticancer drug discovery. FRI-1, methyl 1, 3-dimethyl-5, 8-dioxo-5, 8-dihydro-4-isoquinolinecarboxylate, was previously described as a selective cytotoxic compound on cancer cell lines, however, details on the mechanism of action remain unknown. In this work, we describe that FRI-1 inhibits mitochondrial bioenergetics, producing apoptosis in MCF7 and MDA-MB-231 BC cell lines. FRI-1 decreases the maximal oxygen consumption rate (OCR), ∆ψm, NADH, and ATP levels, with a notable increase of mitochondrial reactive oxygen species (ROS) production, promoting AMPK activation with pro-survival effects. Moreover, FRI-1 inhibits the metabolic remodeling to glycolysis induced by oligomycin. In isolated tumoral mitochondria, FRI-1 increases Complex I and III-dependent OCR state 2, and this is sensitive to rotenone and antimycin A inhibitor additions, suggesting a redox cycling event. Remarkably, α-ketoglutarate and lipoic acid supplementation reversed and promoted, respectively, the FRI-1-induced apoptosis, suggesting that mitochondrial redox disruption affects 2-oxoglutarate dehydrogenase (OGDH) activity, and this is involved in their anticancer mechanism. Consistent with this, the combination of FRI-1 and CPI-613, a dual inhibitor of redox-sensible tricarboxylic acid (TCA) cycle enzymes PDH and OGDH, produced extensive BC cell death. Taken together, our results suggest that FRI-1 exhibits anticancer effects through inhibition of mitochondrial bioenergetics by redox disruption in BC cells. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.